Back

Association of MRI derived hepatic fat fraction with blood pressure in a population-based sample

28 August 2016 (15:49 - 15:56)
Organised by:
Congress Presentation Part of: Metabolic factors and biomarkers Hypertension, other ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Roberto Lorbeer

Ludwig Maximilians University, Munich (Germany)

6 More presentations in this session

Presentation thumbnail
Serum uric acid is independently associated with diastolic dysfunction in apparently healthy subjects with essential hypertension
Doctor G. Georgiopoulos (Athens, GR)
Abstract Slides
Presentation thumbnail
Uric acid levels predict coronary artery disease in essential hypertension: Data from a Greek 8-year-follow-up study
Doctor K. Dimitriadis (Athens, GR)
Abstract Slides
Presentation thumbnail
MicroRNA-21 as a prognostic marker of improvement in arterial stiffness in well-controlled essential hypertension
Doctor M. Marketou (Heraklion, GR)
Abstract Slides
Presentation thumbnail
Parathyroid hormone is independently associated with systolic blood pressure, pulse wave velocity and left ventricular mass index in patients with primary hyperparathyroidism
Miss J. Wetzel (Graz, AT)
Abstract Slides
Presentation thumbnail
Impact of hypertension treatment on immunosenescence parameters
Professor C. Park (Seoul, KR)
Abstract

Access the full session

Session thumbnail
Metabolic factors and biomarkers

The Event

Event poster

ESC Congress 2016

28 August 2016 15:49 CET
You may be interested in
thumbnail
Congress Presentation
Liver fibrosis is associated with left ventricular remodeling: insights into the liver-heart axis
27 August 2023
thumbnail
Congress Presentation
Associations between plasma metabolite profiles and blood pressure: the HELIUS study
27 August 2021
thumbnail
Congress Presentation
Antihypertensive drugs in experimental NAFLD as the first step to the establishment of criteria for choosing appropriate treatment of hypertension in NAFLD carriers
2 September 2019
thumbnail
Congress Presentation
impact of different cardiometabolic risk factors in MASLD: rethinking overweight/obesity criteria.
26 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources